Richard D. Moore

powered by
COS Expertise®
Johns Hopkins University
Internal Medicine
Active Staff
Johns Hopkins University
School of Medicine
Medicine
Professor

Mailing Address

1830 E. Monument Street
Room 8059
Baltimore, Maryland 21287
United States

Contact Information

Phone: (410) 955-2144
Fax: (410) 955-4634
rdmoore@jhmi.edu

Expertise and Research Interests

HIV/AIDS clinical cohort studies

Keywords

COS Keywords:

AIDS, AIDS (Substance Abuse), Antibodies, Clinical Research or Studies, Clinical Trial, Epidemiology, Internal Medicine, Pharmaceuticals, Pharmacoeconomics, Therapy Evaluation.

Additional Terms:

AIDS/HIV, Cohort Studies, Epidemiology, Outcomes, Risk Factors.

Memberships

Society of General Internal Medicine

Publications

  • Moore RD, Wong WM, Keruly JC, McArthur JC, Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea, AIDS, 14(3), 273-8, 18 2000 Abstract
  • Sulkowski MS, Thomas DL, Chaisson RE, Moore RD, Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection, JAMA, 283(1), 74-80, 5 2000 Abstract
  • Moore RD, Chaisson RE, Natural history of HIV infection in the era of combination antiretroviral therapy, AIDS, 13(14), 1933-42, 1 Oct 1999 Abstract
  • Lucas GM, Chaisson RE, Moore RD, Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions, Annals of Internal Medicine, 131(2), 81-7, 20 Jul 1999 Abstract
  • Hall CS, Raines CP, Barnett SH, Moore RD, Gallant JE, Efficacy of salvage therapy containing ritonavir and saquinavir after failure of single protease inhibitor-containing regimens, AIDS, 13(10), 1207-12, 9 Jul 1999 Abstract
  • Moore RD, Human immunodeficiency virus infection, anemia, and survival, Clinical Infectious Diseases, 29(1), 44-9, July 1999 Abstract
  • Bartlett JG, Moore R, A comprehensive plan for managed care of patients infected with human immunodeficiency virus, Clinical Infectious Diseases, 29(1), 50-5, July 1999 Abstract
  • Gebo KA, Chaisson RE, Folkemer JG, Bartlett JG, Moore RD, Costs of HIV medical care in the era of highly active antiretroviral therapy, AIDS, 13(8), 963-9, 28 May 1999 Abstract
  • Oursler KA, Moore RD, Chaisson RE, Risk factors for cryptococcal meningitis in HIV-infected patients, AIDS Research and Human Retroviruses, 15(7), 625-31, 1 May 1999 Abstract
  • Sterling T R, Brehm W T, Moore R D, Chaisson R E, Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world, INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 3(3), 248-54, 1999 Abstract
  • Moore R D, Cheever L, Keruly J C, Chaisson R E, Lack of sex difference in CD4 to HIV-1 RNA viral load ratio letter, LANCET, 353(9151), 463-4, 6 1999 Abstract
  • Gallant JE, Chaisson RE, Keruly JC, Moore RD, Stavudine in zidovudine \(ZDV\)-experienced compared with ZDV-naive patients, AIDS, 13(2), 225-9, 4 Feb 1999 Abstract
  • Cromwell D M, Bass E B, Steinberg E P, Yasui Y, Ravich W J, Hendrix T R, McLeod S F, Moore R D, Can restrictions on reimbursement for anti-ulcer drugs decrease Medicaid pharmacy costs without increasing hospitalizations, HEALTH SERVICES RESEARCH, 33(6), 1593-610, 1999 Abstract
  • Moore R D, Schistocytosis and a thrombotic microangiopathy-like syndrome in hospitalized HIV-infected patients, AMERICAN JOURNAL OF HEMATOLOGY, 60(2), 116-20, 1999 Abstract
  • Lumadue JA, Manabe YC, Moore RD, Belitsos PC, Sears CL, Clark DP, A clinicopathologic analysis of AIDS-related cryptosporidiosis, AIDS, 12(18), 2459-66, 24 Dec 1998 Abstract
  • Sulkowski M S, Chaisson R E, Karp C L, Moore R D, Margolick J B, Quinn T C, The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults, JOURNAL OF INFECTIOUS DISEASES, 178(6), 1642-8, 1998 Abstract
  • Gallant J E, Chaisson R E, Moore R D, The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complications see comments, CHEST, 114(5), 1258-63, 1998 Abstract
  • Moore R D, Keruly J C, Chaisson R E, Anemia and survival in HIV infection, JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 19(1), 29-33, 1 1998 Abstract
  • Manabe Y C, Clark D P, Moore R D, Lumadue J A, Dahlman H R, Belitsos P C, Chaisson R E, Sears C L, Cryptosporidiosis in patients with AIDS: correlates of disease and survival, CLINICAL INFECTIOUS DISEASES, 27(3), 536-42, 1998 Abstract
  • Sterling T R, Moore R D, Graham N M, Astemborski J, Vlahov D, Chaisson R E, Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M avium complex disease, AIDS, 12(12), 1451-7, 20 1998 Abstract
  • Celentano D D, Vlahov D, Cohn S, Shadle V M, Obasanjo O, Moore R D, Self-reported antiretroviral therapy in injection drug users, JAMA, 280(6), 544-6, 12 1998 Abstract
  • Beall D P, Scott W W Jr, Kuhlman J E, Hofmann L V, Moore R D, Mundy L M, Utilization of computed tomography in patients hospitalized with community-acquired pneumonia, Maryland Medical Journal, 47(4), 182-7, August 1998 Abstract
  • Bartlett J G, Moore R D, Improving HIV therapy, SCIENTIFIC AMERICAN, 279(1), 84-7, 89, 1998 Abstract
  • Eldred L J, Wu A W, Chaisson R E, Moore R D, Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease, JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 18(2), 117-25, 1 1998 Abstract
  • Cromwell D M, Moore R D, Brensinger J D, Petersen G M, Bass E B, Giardiello F M, Cost analysis of alternative approaches to colorectal screening in familial adenomatous polyposis, GASTROENTEROLOGY, 114(5), 893-901, 1998 Abstract
  • Lucas G M, Lechtzin N, Puryear D W, Yau L L, Flexner C W, Moore R D, Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes, CLINICAL INFECTIOUS DISEASES, 26(5), 1127-33, 1998 Abstract
  • Mundy L M, Oldach D, Auwaerter P G, Gaydos C A, Moore R D, Bartlett J G, Quinn T C, Implications for macrolide treatment in community-acquired pneumonia Hopkins CAP Team see comments, CHEST, 113(5), 1201-6, 1998 Abstract
  • Agnew D G, Lima A A, Newman R D, Wuhib T, Moore R D, Guerrant R L, Sears C L, Cryptosporidiosis in northeastern Brazilian children: association with increased diarrhea morbidity, JOURNAL OF INFECTIOUS DISEASES, 177(3), 754-60, 1998 Abstract
  • Moore R D, Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort, JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 17 Suppl 1(1077-9450), S38-41, 1998 Abstract
  • Chaisson R E, Gallant J E, Keruly J C, Moore R D, Impact of opportunistic disease on survival in patients with HIV infection, AIDS, 12(1), 29-33, 1 1998 Abstract
  • Mehta S, Moore R D, Graham N M, Potential factors affecting adherence with HIV therapy [editorial], Aids, 11(14), 1665-70, 15 Nov 1997 Abstract
  • Chambers F G, Koshy S S, Saidi R F, Clark D P, Moore R D, Sears C L, Bacteroides fragilis toxin exhibits polar activity on monolayers of human intestinal epithelial cells (T84 cells) in vitro, INFECTION AND IMMUNITY, 65(9), 3561-70, 1997 Abstract
  • Moore R D, Chaisson R E, Cost-utility analysis of prophylactic treatment with oral ganciclovir for cytomegalovirus retinitis, JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 16(1), 15-21, 1 1997 Abstract
  • Styrt B A, Chaisson R E, Moore R D, Prior antimicrobials and staphylococcal bacteremia in HIV-infected patients, AIDS, 11(10), 1243-8, 1997 Abstract
  • Dal Pan G J, Skolasky R L, Moore R D, The impact of neurologic disease on hospitalizations related to human immunodeficiency virus infection in Maryland, 1991-1992, ARCHIVES OF NEUROLOGY, 54(7), 846-52, 1997 Abstract
  • Regan F, Petronis J, Bohlman M, Rodriguez R, Moore R, Perirenal MR high signal--a new and sensitive indicator of acute ureteric obstruction, CLINICAL RADIOLOGY, 52(6), 445-50, 1997 Abstract
  • Moore R D, Chaisson R E, Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland, JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 14(3), 223-31, 1 1997 Abstract
  • Chaisson R E, Moore R D, Prevention of opportunistic infections in the era of improved antiretroviral therapy see comments, JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 16 Suppl 1(1077-9450), S14-22, 1997 Abstract
  • Maenza J R, Merz W G, Romagnoli M J, Keruly J C, Moore R D, Gallant J E, Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology, CLINICAL INFECTIOUS DISEASES, 24(1), 28-34, 1997 Abstract
  • Charache S, Barton F B, Moore R D, Terrin M L, Steinberg M H, Dover G J, Ballas S K, McMahon R P, Castro O, Orringer E P, Hydroxyurea and sickle cell anemia Clinical utility of a myelosuppressive 'switching' agent The Multicenter Study of Hydroxyurea in Sickle Cell Anemia, MEDICINE, 75(6), 300-26, 1996 Abstract
  • Moore R D, Chaulk C P, Griffiths R, Cavalcante S, Chaisson R E, Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis, AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 154(4 Pt 1), 1013-9, 1996 Abstract
  • Moore R D, Fortgang I, Keruly J, Chaisson R E, Adverse events from drug therapy for human immunodeficiency virus disease, AMERICAN JOURNAL OF MEDICINE, 101(1), 34-40, 1996 Abstract
  • Moore R D, Keruly J C, Chaisson R E, Duration of the survival benefit of zidovudine therapy in HIV infection, ARCHIVES OF INTERNAL MEDICINE, 156(10), 1073-7, 27 1996 Abstract
  • Chaisson R E, Keruly J C, McAvinue S, Gallant J E, Moore R D, Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection, JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 11(5), 455-9, 15 1996 Abstract
  • Gebo K A, Moore R D, Keruly J C, Chaisson R E, Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients, JOURNAL OF INFECTIOUS DISEASES, 173(4), 857-62, 1996 Abstract
  • Moore R D, Chaisson R E, Natural history of opportunistic disease in an HIV-infected urban clinical cohort, ANNALS OF INTERNAL MEDICINE, 124(7), 633-42, 1 1996 Abstract
  • Maenza J R, Keruly J C, Moore R D, Chaisson R E, Merz W G, Gallant J E, Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients, JOURNAL OF INFECTIOUS DISEASES, 173(1), 219-25, 1996 Abstract
  • Auwaerter P G, Oldach D, Mundy L M, Burton A, Warner M L, Vance E, Moore R D, Rossi C A, Hantavirus serologies in patients hospitalized with community-acquired pneumonia, JOURNAL OF INFECTIOUS DISEASES, 173(1), 237-9, 1996 Abstract
  • Manabe Y C, Vinetz J M, Moore R D, Merz C, Charache P, Bartlett J G, Clostridium difficile colitis: an efficient clinical approach to diagnosis see comments, ANNALS OF INTERNAL MEDICINE, 123(11), 835-40, 1 1995 Abstract
  • Charache S, Terrin M L, Moore R D, Dover G J, McMahon R P, Barton F B, Waclawiw M, Eckert S V, Design of the multicenter study of hydroxyurea in sickle cell anemia Investigators of the Multicenter Study of Hydroxyurea, CONTROLLED CLINICAL TRIALS, 16(6), 432-46, 1995 Abstract
  • Moore R D, Chaisson R E, Survival analysis of two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex in AIDS, AIDS, 9(12), 1337-42, 1995 Abstract
  • Moore R D, Keruly J C, Chaisson R E, Neutropenia and bacterial infection in acquired immunodeficiency syndrome see comments, ARCHIVES OF INTERNAL MEDICINE, 155(18), 1965-70, 9 1995 Abstract
  • Mundy L M, Auwaerter P G, Oldach D, Warner M L, Burton A, Vance E, Gaydos C A, Joseph J M, Gopalan R, Moore R D, et al, Community-acquired pneumonia: impact of immune status, American Journal of Respiratory and Critical Care Medicine, 152(4 Pt 1), 1309-15, October 1995 Abstract
  • Chaisson R E, Keruly J C, Moore R D, Race, sex, drug use, and progression of human immunodeficiency virus disease see comments, NEW ENGLAND JOURNAL OF MEDICINE, 333(12), 751-6, 21 1995 Abstract
  • Fortgang I S, Belitsos P C, Chaisson R E, Moore R D, Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy, AMERICAN JOURNAL OF GASTROENTEROLOGY, 90(9), 1433-6, 1995 Abstract
  • Glesby M J, Moore R D, Chaisson R E, Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus see comments, CLINICAL INFECTIOUS DISEASES, 21(2), 370-5, 1995 Abstract
  • Gallant J E, Moore R D, Keruly J, Richman D D, Chaisson R E, Lack of association between acyclovir use and survival in patients with advanced human immunodeficiency virus disease treated with zidovudine Zidovudine Epidemiology Study Group see comments, JOURNAL OF INFECTIOUS DISEASES, 172(2), 346-52, 1995 Abstract
  • Charache S, Terrin M L, Moore R D, Dover G J, Barton F B, Eckert S V, McMahon R P, Bonds D R, Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia see comments, NEW ENGLAND JOURNAL OF MEDICINE, 332(20), 1317-22, 18 1995 Abstract
  • Gallant J E, McAvinue S M, Moore R D, Bartlett J G, Stanton D L, Chaisson R E, The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia see comments, CHEST, 107(4), 1018-23, 1995 Abstract
  • Fortgang I S, Moore R D, Hospital admissions of HIV-infected patients from 1988 to 1992 in Maryland, JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 8(4), 365-72, 1 1995 Abstract
  • Chang Y C, Smith K D, Moore R D, Serjeant G R, Dover G J, An analysis of fetal hemoglobin variation in sickle cell disease: the relative contributions of the X-linked factor, beta-globin haplotypes, alpha-globin gene number, gender, and age, BLOOD, 85(4), 1111-7, 15 1995 Abstract
  • Moore R D, Chaisson R E, Hidalgo J, The efficacy of zidovudine is time limited letter; comment, JAMA, 272(13), 1001; discussion 100, 5 1994 Abstract
  • Stanton D L, Wu A W, Moore R D, Rucker S C, Piazza M P, Abrams J E, Chaisson R E, Functional status of persons with HIV infection in an ambulatory setting, JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 7(10), 1050-6, 1994 Abstract
  • Gallant J E, Moore R D, Chaisson R E, Prophylaxis for opportunistic infections in patients with HIV infection see comments, ANNALS OF INTERNAL MEDICINE, 120(11), 932-44, 1 1994 Abstract
  • Moore R D, Hidalgo J, Bareta J C, Chaisson R E, Zidovudine therapy and health resource utilization in AIDS, JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 7(4), 349-54, 1994 Abstract
  • Moore R D, Stanton D, Gopalan R, Chaisson R E, Racial differences in the use of drug therapy for HIV disease in an urban community see comments, NEW ENGLAND JOURNAL OF MEDICINE, 330(11), 763-8, 17 1994 Abstract
  • Gallant J E, Moore R D, Richman D D, Keruly J, Chaisson R E, Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine Zidovudine Epidemiology Study Group, ARCHIVES OF INTERNAL MEDICINE, 154(5), 566-72, 14 1994 Abstract
  • Moore R D, Screening and assessment of alcohol and other drug abuse, MARYLAND MEDICAL JOURNAL, 43(1), 35-9, 1994 Abstract
  • Powe N R, Moore R D, Steinberg E P, Adverse reactions to contrast media: factors that determine the cost of treatment, AJR American Journal of Roentgenology, 161(5), 1089-95, November 1993 Abstract
  • Glesby M J, Moore R D, Chaisson R E, Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine Zidovudine Epidemiology Study Group, JOURNAL OF INFECTIOUS DISEASES, 168(5), 1264-8, 1993 Abstract
  • Chaisson R E, Stanton D L, Gallant J E, Rucker S, Bartlett J G, Moore R D, Impact of the 1993 revision of the AIDS case definition on the prevalence of AIDS in a clinical setting, AIDS, 7(6), 857-62, 1993 Abstract
  • Powe N R, Davidoff A J, Moore R D, Brinker J A, Anderson G F, Litt M R, Gopalan R, Graziano S L, Steinberg E P, Net costs from three perspectives of using low versus high osmolality contrast medium in diagnostic angiocardiography see comments, JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 21(7), 1701-9, 1993 Abstract
  • Wright C, Moore R D, Grodin D M, Spyker D A, Gill E V, Screening for disulfiram-induced liver test dysfunction in an inpatient alcoholism program, Alcoholism, Clinical and Experimental Research, 17(1), 184-6, February 1993 Abstract
  • Baldwin W A, Rosenfeld B A, Breslow M J, Buchman T G, Deutschman C S, Moore R D, Substance abuse-related admissions to adult intensive care, CHEST, 103(1), 21-5, 1993 Abstract
  • Gallant J E, Moore R D, Richman D D, Keruly J, Chaisson R E, Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine The Zidovudine Epidemiology Study Group see comments, JOURNAL OF INFECTIOUS DISEASES, 166(6), 1223-7, 1992 Abstract
  • Chaisson R E, Keruly J, Richman D D, Moore R D, Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine The Zidovudine Epidemiology Group, ARCHIVES OF INTERNAL MEDICINE, 152(10), 2009-13, 1992 Abstract
  • Chaisson R E, Moore R D, Richman D D, Keruly J, Creagh T, Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine The Zidovudine Epidemiology Study Group, AMERICAN REVIEW OF RESPIRATORY DISEASE, 146(2), 285-9, 1992 Abstract
  • Moore R D, Keruly J, Richman D D, Creagh-Kirk T, Chaisson R E, Natural history of advanced HIV disease in patients treated with zidovudine The Zidovudine Epidemiology Study Group, AIDS, 6(7), 671-7, 1992 Abstract
  • Kimball A W, Friedman L A, Moore R D, Nonlinear modeling of alcohol consumption for analysis of beverage type effects and beverage preference effects, AMERICAN JOURNAL OF EPIDEMIOLOGY, 135(11), 1287-92, 1 1992 Abstract
  • Charache S, Dover G J, Moore R D, Eckert S, Ballas S K, Koshy M, Milner P F, Orringer E P, Phillips G Jr, Platt O S, Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia see comments, BLOOD, 79(10), 2555-65, 15 1992 Abstract
  • Moore R D, Lerner S A, Levine D P, Nephrotoxicity and ototoxicity of aztreonam versus aminoglycoside therapy in seriously ill nonneutropenic patients, JOURNAL OF INFECTIOUS DISEASES, 165(4), 683-8, 1992 Abstract
  • Gopalan R, Santora P, Stokes E J, Moore R D, Levine D M, Evaluation of a model curriculum on substance abuse at The Johns Hopkins University School of Medicine, ACADEMIC MEDICINE, 67(4), 260-6, 1992 Abstract
  • Moore R D, Steinberg E P, Powe N R, Brinker J A, Fishman E K, Graziano S, Gopalan R, Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial, RADIOLOGY, 182(3), 649-55, 1992 Abstract
  • Steinberg E P, Moore R D, Powe N R, Gopalan R, Davidoff A J, Litt M, Graziano S, Brinker J A, Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography [see comments], New England Journal of Medicine, 326(7), 425-30, 13 Feb 1992 Abstract
  • Moore RD, Steinberg EP, Powe NR, Brinker JA, Fishman EK, Graziano S, Gopalan R, Nephrotoxicity of High-Osmolality versus Low-Osmolality Contrast Media: Randomized Clinical Trial, Radiology, 182, 649-55, 1992
  • Easterbrook P J, Keruly J C, Creagh-Kirk T, Richman D D, Chaisson R E, Moore R D, Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease Zidovudine Epidemiology Study Group see comments, JAMA, 266(19), 2713-8, 20 1991 Abstract
  • Brinker J, Steinberg E, Moore R, Powe N, Graziano S, Gopalan R, Litt M, The effects of intracoronary contrast in the denervated human heart, Investigative Radiology, 26 Suppl 1, S118-9; discussion S, November 1991 Abstract
  • Steinberg E P, Moore R D, Brinker J A, Fishman E K, Powe N R, Graziano S L, Gopalan R, Nephrotoxicity of low osmolality contrast media versus high osmolality media, INVESTIGATIVE RADIOLOGY, 26 Suppl 1(0020-9996), S86; discussion S88-, 1991 Abstract
  • Sanders J W, Powe N R, Moore R D, Ceftazidime monotherapy for empiric treatment of febrile neutropenic patients: a meta-analysis, JOURNAL OF INFECTIOUS DISEASES, 164(5), 907-16, 1991 Abstract
  • Umbricht-Schneiter A, Santora P, Moore R D, Alcohol abuse: comparison of two methods for assessing its prevalence and associated morbidity in hospitalized patients see comments, AMERICAN JOURNAL OF MEDICINE, 91(2), 110-8, 1991 Abstract
  • Duggan A K, Adger H Jr, McDonald E M, Stokes E J, Moore R, Detection of alcoholism in hospitalized children and their families see comments, AMERICAN JOURNAL OF DISEASES OF CHILDREN, 145(6), 613-7, 1991 Abstract
  • Moore R D, Hidalgo J, Sugland B W, Chaisson R E, Zidovudine and the natural history of the acquired immunodeficiency syndrome see comments, NEW ENGLAND JOURNAL OF MEDICINE, 324(20), 1412-6, 16 1991 Abstract
  • Moore R D, Creagh-Kirk T, Keruly J, Link G, Wang M C, Richman D, Chaisson R E, Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease Zidovudine Epidemiology Study Group, ARCHIVES OF INTERNAL MEDICINE, 151(5), 981-6, 1991 Abstract
  • Moore R D, Kessler H, Richman D D, Flexner C, Chaisson R E, Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine, JAMA, 265(17), 2208-11, 1 1991 Abstract
  • Livingston I L, Levine D M, Moore R D, Social integration and black intraracial variation in blood pressure, Ethnicity and Disease, 1(2), 135-49, 1 Apr 1991 Abstract
  • Moore RD, Hidalgo J, Sugland B, Chaisson RE, Impact of Zidovudine on the Natural History of Acquired Immune Deficiency Syndrome, New England Journal of Medicine, 324, 1412-6, 1991
  • Moore RD, Kessler H, Richman DD, Flexner C, Chaisson RE, Non-Hodgkins Lymphoma in Patients with Advanced HIV Infection Treated with Zidovudine, JAMA, 265, 2208-11, 1991
  • Wright C, Moore R D, Disulfiram treatment of alcoholism published erratum appears in Am J Med 1991 Oct;91(4):446, AMERICAN JOURNAL OF MEDICINE, 88(6), 647-55, 1990 Abstract
  • Moore R D, Mead L, Pearson T A, Youthful precursors of alcohol abuse in physicians, AMERICAN JOURNAL OF MEDICINE, 88(4), 332-6, 1990 Abstract
  • Moore R D, Levine D M, Southard J, Entwisle G, Shapiro S, Alcohol consumption and blood pressure in the 1982 Maryland Hypertension Survey, AMERICAN JOURNAL OF HYPERTENSION, 3(1), 1-7, 1990 Abstract
  • Klag M J, Moore R D, Whelton P K, Sakai Y, Comstock G W, Alcohol consumption and blood pressure: a comparison of native Japanese to American men, JOURNAL OF CLINICAL EPIDEMIOLOGY, 43(12), 1407-14, 1990 Abstract

Profile Details

Last Updated: 5/1/2006

COS Expertise ID #1140844
Reference this profile directly: http://myprofile.cos.com/moore228